We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sio Gene Therapies Inc | NASDAQ:SIOX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.415 | 0.405 | 0.43 | 0 | 01:00:00 |
Delaware
|
001-37418
|
85-3863315
|
||||||||||||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
130 West 42nd Street
26th Floor
New York, New York 10036
(Address of principal executive offices) (Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|||||||
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|||||||
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|||||||
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each Class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||||||||||
Common Stock, par value $0.00001 per share
|
SIOX
|
The Nasdaq Stock Market LLC
|
SIO GENE THERAPIES INC.
|
|||||||||||||||||
Dated:
|
August 12, 2021
|
||||||||||||||||
By:
|
/s/ David Nassif
|
||||||||||||||||
Name:
|
David Nassif
|
||||||||||||||||
Title:
|
Chief Financial Officer and General Counsel
|
1 Year Sio Gene Therapies Chart |
1 Month Sio Gene Therapies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions